cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ A Potent and Specific Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue Decline: Cell Metabolism Heavy-chain antibody targeting of CD38
Heavy chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs Scientific Reports Nicotinamide Riboside and CD38: Covalent Inhibition and Live Cell Labeling JACS Au Nicotinamide N Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target Roles of Nicotinamide N Methyltransferase in Obesity and Type 2 Diabetes PMC Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect
Pay in 4 interest-free payments of $7.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10





